
Full text loading...
I read the recent article on the relationship between thyroglobulin and recurrence of thyroid cancer with great interest. Papageorgiou et al. concluded that 'Although low, a cutoff Tg level of 1.3 ng/ml represents a simple indication for further investigation in patients receiving thyroxine after completion of treatment for thyroid cancer, in the absence of measurement of anti-Tg auto-antibodies'.
Article metrics loading...